The mechanisms responsible for drug resistance include the acquisition of mutations in the FLT3 gene, the activation of other pro-survival pathways and microenvironment-mediated resistance [22,23]; however, additional mechanisms responsible for the drug resistance of FLT3-ITD+ AML cells remain to be investigated. The gene discussed is FLT3; the disease is acute myeloid leukemia.